U.S. Markets open in 9 hrs 2 mins

China Pharma Holdings, Inc. (CPHI)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.7516+0.0206 (+2.82%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7310
Open0.7400
Bid0.0000 x 800
Ask0.0000 x 45900
Day's Range0.7400 - 0.7690
52 Week Range0.3200 - 1.4000
Volume1,370,449
Avg. Volume1,201,840
Market Cap34.258M
Beta (5Y Monthly)0.43
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
    PR Newswire

    China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.

  • China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks
    PR Newswire

    China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that the masks produced by its subsidiary Hainan Helpson Medicine & Biotechniqe Co., Ltd. has received multiple certifications, and have been listed on the Whitelist ("Whitelist" refers to the "List of Non-Medical Mask Manufacturers that have Obtained Foreign Standard Certification or Registration" and "List of Medical Material Production Enterprises that have Obtained Foreign Standard Certification or Registration" as indicated in document No. 12 issued by the Chinese government in 2020).

  • China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results
    PR Newswire

    China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

    China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2020.